🚀 Revolutionizing Aortic Stenosis Detection with ECGs 🏥💡 Aortic stenosis (AS) remains one of the most underdiagnosed and undertreated cardiovascular conditions, despite its high burden and excellent treatment options. Early detection is critical, yet traditional methods often fall short due to non-specific symptoms, inconsistent auscultation practices, and limited echocardiography access. At AccurKardia, we’re changing the paradigm. Our AI-powered AK-AVS solution leverages existing ECG data, stored in health system EHRs, to identify moderate-to-severe AS with high accuracy—without the need for additional tests or equipment. 🔬 Validated using the Mayo Clinic Platform_Accelerate Cohort 3 and ARIC datasets, AK-AVS has demonstrated robust performance across diverse patient populations and exceeds many gold standard diagnostics. 📢 Download our latest white paper to explore: 🔹 The challenges of AS detection 🔹 How AI-based ECG screening aids early diagnosis and therapy referral 🔹 Key validation metrics and clinical impact 📄 https://lnkd.in/gwNfECcg Join us in shaping the future of cardiovascular care. Let’s detect AS earlier, treat patients sooner, and save more lives. #Cardiology #AIinHealthcare #AorticStenosis #ECG #MedicalInnovation #HealthcareTech #AccurKardia #MedTech
About us
AccurKardia is an ECG-led diagnostics software company focused on transforming ECG data into a more powerful diagnostic tool and broad biomarker to improve patient outcomes and save lives globally. With initial applications in cardiology, the company offers transformative, cloud-based diagnostic tools, including AccurECG™, an FDA-cleared Class II software as a medical device (SaMD) for fully automated, near real-time ECG interpretation. AccurKardia’s AK+ Guard™—an AI-driven hyperkalemia detection solution using Lead I ECG data to help patients with conditions like CKD and ESRD identify life-threatening high potassium levels earlier—received FDA Breakthrough Device Designation and was accepted into the FDA Total Product Life Cycle (TAP) Advisory Program in December 2024. The company’s aortic stenosis detection model, AK-AVS™, received FDA Breakthrough Device Designation in October 2024. AccurKardia completed the 2024 Cohort of MedTech Innovator (MTI) and was one of five companies selected for the inaugural American Heart Association’s Heart and Brain Health Accelerator track within MTI.
- Website
-
http://www.accurkardia.com
External link for AccurKardia
- Industry
- Software Development
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2019
- Specialties
- artificial intelligence, AI, cardiac healthcare, ecg analysis, healthtech, medtech, IoT, digitalhealth, medical devices, remote patient monitoring, diagnostics, biomarker, EKG, Aortic Stenosis, ECG, Biomarkers, Hyperkalemia, ESRD, and CKD
Locations
-
Primary
101 Avenue of the Americas
New York, NY 10013, US
Employees at AccurKardia
Updates
-
AccurKardia reposted this
📈 Advanced ECG analytics are redefining diagnostics! Juan C Jimenez, CEO of AccurKardia, explores how ECG technology is shaping the future of global healthcare. #ECG #Cardiology
-
-
Our Co-Founder and CEO, Juan C Jimenez, will be speaking at HITLAB’s February 2025 Digital Health Symposium tomorrow, February 27th! During this virtual event, he will discuss how AccurKardia harnesses ECG-led diagnostics as a powerful biomarker to transform patient care globally. Don’t miss the chance to learn about our FDA-cleared Class II SaMD (AccurECG™) and other breakthrough solutions—such as AK+ Guard™ and AK-AVS™—that are shaping the future of cardiology and digital health. #DigitalHealth #Cardiology #ECG #AIinHealthcare #HealthcareInnovation
🆕 HITLAB February Symposium | New Speaker! HITLAB is honoured to welcome Juan C Jimenez, Co-Founder & CEO, AccurKardia to speak at the HITLAB Symposium 2025 next week on February 27, 2025, at 11 AM ET. This edition of the Symposium focuses on Digital Heartbeats of Health: Revolutionizing Digital Health with AI. 👉 Registration is free—Register now! Plus, get a chance to win an exclusive 1-year Breakthrough Fellowship worth $99. 👉 Register: https://lnkd.in/dXZE_4Dz #HITLABSymposium #DigitalHealth #AIinHealthcare #HealthcareInnovation #HealthTech #MedTech #ArtificialIntelligence #FutureofHealth
-
-
We're excited to share this insightful podcast featuring our very own Ken Nelson — a cardiac monitoring veteran, investor, and Strategic Advisor at AccurKardia. In this engaging conversation with Omar M. Khateeb, Ken dives into the latest innovations in cardiactech, and his unique perspective on healthcare investments is truly inspiring. Tune in to hear his journey and vision for the future of cardiac care. Check out the full discussion here: https://lnkd.in/eDRs3mZD #MedTech #Cardiology #HealthcareInvestment #Innovation #AccurKardia
🎙️ Host of MedTech's #1 Podcast | Helping Medtech Grow Sales Pipeline & Find Investors Using Social Media | Proud Husband & Father | Avid Reader | Jiu Jitsu @Carlson Gracie | Mentor | Coach
Ken Nelson has built a career at the intersection of cardiac technology, sales leadership, and medtech investment. With years of experience in commercial strategy and board leadership, he’s now shaping the future of cardiac innovation and investment. In our latest podcast episode, Ken shares his journey and insights into where the industry is headed. Here’s why you should listen: 🔹 Sales to Investment – How Ken transitioned into medtech investing 🔹 Emerging Trends – What’s shaping the future of cardiac monitoring 🔹 Investment Strategies – Key insights for medtech investors 🔹 Tech to Watch – Innovations changing the game in cardiology 🔹 Lessons from Experience – Insights from decades in medtech Ken’s expertise makes this a must-listen for medtech professionals, investors, and innovators. #medtech #cardiology #healthcareinvestment #digitalhealth #medicaldevices #leadership #innovation #startups #healthcare
-
ECGs: A Window into Whole-Body Health We’ve long believed that an ECG is far more than just a heart test. A groundbreaking new study using unsupervised deep learning found 645 prevalent and 606 incident disease associations in ECGs—spanning cardiac, respiratory, endocrine, and more. Even rheumatoid arthritis, which has no classic ECG signature, revealed subtle waveform changes. Why It Matters: This research strongly supports our view of ECGs as a “digital biomarker” for overall health. By harnessing AI and powerful computing, we can unlock hidden signals that transform a routine ECG into a far-reaching screening tool. Check out the full publication: Unsupervised Deep Learning of ECGs Enables Scalable Human Disease Profiling by Sam Friedman, et al. https://lnkd.in/e5YRmNSG Key Takeaways: *Broad Disease Detection: ECG signals hint at conditions from hypertension to diabetes. *Subclinical Insights: Deep learning uncovers waveform patterns traditional interpretation may miss. *Big Opportunity: Wearable ECG data + AI = noninvasive, population-level health monitoring. #BetterOutcomes #ECG #EKG #Innovation #AI
-
We’re proud to share a snapshot from our company-wide call where the team wore red in support of National Wear Red Day! Together, we’re raising awareness about the importance of heart health for women everywhere. By uniting our passion for better outcomes, we can help make a positive impact—one heartbeat at a time.
-
-
This Friday, AccurKardia is proud to join the movement on National Wear Red Day® in support of women's heart health! In celebration of American Heart Month, we're taking action to empower healthier lifestyles and stronger communities. Join us in connecting to a healthier you: Learn: Gain insights into risk reduction, prevention, and healthy living. Engage: Participate in community events and support networks. Empower: Inspire the next generation through research and STEM careers. Let’s rock our red, share our stories, and create a ripple effect of awareness. How are you showing your support? Comment below and let’s inspire each other! Discover more ways to get connected at GoRedforWomen.org #WearRedDay #HeartMonth #WomenHealth #Innovation #BetterOutcomes
-
We're thrilled to announce that our new website is live! Dive into how we're transforming ECGs into a more powerful diagnostic tool and broad biomarker—with breakthrough applications in cardiology and beyond. Explore the future of heart health at www.accurkardia.com and join us in our mission to improve patient outcomes and save lives.
-
February is American Heart Month—a time to spotlight the importance of cardiovascular health and proactive care. This month, we encourage everyone to take a moment to learn about the risk factors, preventive measures, and lifestyle changes that can make a lasting impact on heart health. Discover more about how you can contribute to a healthier future by visiting trusted resources like the American Heart Association. Together, let’s champion heart health—one ECG at a time. #AmericanHeartMonth #HeartHealth #CardiovascularCare #BetterOutcomes #Innovation
-
Hyperkalemia is a serious concern for patients with CKD and ESRD, but real-time remote detection can make a critical difference. In this Nephrology Times/DocWire News interview, Dr. Wei Ling Lau (https://lnkd.in/eW7EpX2r) discusses how AK+ Guard™ uses Lead I ECG data for earlier intervention and improved outcomes. https://lnkd.in/eHXdxgJv #Hyperkalemia #AI #ECG #CKD #ESRD #Innovation #DigitalHealth #BetterOutcomes